Welcome to our dedicated page for Soren Acquisition news (Ticker: SORNW), a resource for investors and traders seeking the latest updates and insights on Soren Acquisition stock.
The SORNW news page tracks developments related to the redeemable warrants of Soren Acquisition Corp., a blank check company formed to pursue a business combination. Company announcements describe Soren Acquisition Corp. as focused on completing a transaction with an attractive target business in the healthcare industry, while retaining flexibility to evaluate opportunities across other sectors.
News for SORNW typically originates from corporate press releases about Soren Acquisition Corp.’s capital markets activity and its progress as a special purpose acquisition company. This includes information about its initial public offering of units under the symbol SORNU, the structure of those units, and the expected separate listing of the Class A ordinary shares and warrants under the symbols SORN and SORNW on Nasdaq.
As a SPAC, notable updates may include announcements about potential or completed business combinations, changes in the status of its units, shares, or warrants, and other disclosures tied to its search for a suitable healthcare-focused target. Readers following SORNW news can use this page to monitor how corporate actions and transaction milestones could affect the warrants associated with Soren Acquisition Corp.
By reviewing the SORNW news feed, investors and observers can see how the company describes its objectives, financing transactions, and any future steps toward identifying and combining with one or more businesses, as reported through official news releases.
Soren Acquisition Corp (Nasdaq: SORN) announced that, effective February 27, 2026, holders of units may elect to separately trade Class A ordinary shares and warrants included in the Units.
The Class A Ordinary Shares will trade as SORN, the whole warrants as SORNW, and unsplit Units will continue trading as SORNU. Each Unit contains one Class A Ordinary Share and one-third of a warrant; each whole warrant is exercisable for one share at $11.50. No fractional warrants will be issued. BTIG acted as sole book-running manager.
Soren Acquisition Corp (NASDAQ:SORN) closed an initial public offering of 25,300,000 units (including a 3,300,000-unit over-allotment) at $10.00 per unit, generating $253,000,000 in gross proceeds. Units began trading on January 7, 2026 on the Nasdaq Global Market under the symbol SORNU; once separated, Class A shares and warrants are expected to list as SORN and SORNW. Each unit comprises one Class A ordinary share and one‑third of one redeemable warrant; each whole warrant is exercisable to buy one Class A share at $11.50. The company is a blank check company focused on completing a business combination, with management led by CEO Arghavan Di Rezze and CFO Jamie Weber.
Soren Acquisition Corp (NASDAQ:SORN) priced an initial public offering of 22,000,000 units at $10.00 per unit, representing gross proceeds of $220,000,000, with trading of units expected to begin on January 7, 2026 under the ticker SORNU.
Each unit includes one Class A ordinary share and one-third of a redeemable warrant; whole warrants will trade separately as SORNW and will entitle holders to buy one share at $11.50 per share. The offering is expected to close on January 8, 2026 and the underwriters have a 45-day over-allotment option to purchase up to 3,300,000 additional units.
The company is a blank check vehicle focused on healthcare business combinations and named its management and board, with BTIG acting as sole book-running manager.